Immunoadsorption as a novel therapy for refractory idiopathic inflammatory myopathies-a retrospective observational study

Further Publications Immunology

Disease characteristics and medications use in idiopathic inflammatory myopathy: a multi-center prospective observational study of decentralized remote vs. traditional clinic enrollment

Rheumatology (Oxford)

Keret S, Silva RL, Chandra T, Gkiaouraki E, Pongtarakulpanit N, Sriram S, Moghadam-Kia S, Oddis CV, Aggarwal R

doi: 10.1093/rheumatology/keae467

Further Publications Immunology

Autoantibodies and damage in patients with idiopathic inflammatory myopathies: A longitudinal multicenter study from the MYONET international network

Semin Arthritis Rheum

Espinosa-Ortega F, Lodin K, Dastmalchi M, Vencovsky J, Diederichsen LP, Shinjo SK, Danieli MG, Selva-O'Callaghan A, de Visser M, Griger Z, Ceribelli A, Gómez-Martin D, Andersson H, Mercado MV, Chinoy H, Lilleker JB, New P, Krogh NS, Lundberg IE, Alexanderson H, MYONET Registry Study Group

doi: 10.1016/j.semarthrit.2024.152529

Further Publications Rheumatology

Construct validity of PROMIS pain interference, fatigue, and physical function as patient-reported outcomes in adults with idiopathic inflammatory myopathies: An international study from the OMERACT myositis working group

Semin Arthritis Rheum

Romich E, Saygin D, DiRenzo D, Mecoli CA, de Groot I, Lodin K, Regardt M, Sarver C, Kim JY, Park JK, Beer K, Needham M, Alexanderson H, Christopher-Stine L, de Visser M, Raaphorst J, OMERACT Myositis Working Group

doi: 10.1016/j.semarthrit.2024.152534

Further Publications Rheumatology

Recruitment rate comparison between a virtual tele-research cohort and a traditional center-based cohort in idiopathic inflammatory myopathy

Rheumatology (Oxford)

Moghadam-Kia S, Aggarwal A, Venuturupalli S, Keret S, Pongtarakulpanit N, Riley M, Mahajan S, Scaramangas-Plumley D, Patel A, Kelley J, Tiniakou E, Oddis CV, Aggarwal R, Group MS

doi: 10.1093/rheumatology/keaf217

Melanoma and Skin Cancer

Radiation therapy on lentigo maligna: A single-centre retrospective study on 91 patients

Ann Dermatol Venereol

Canu D, Kabore R, Cogrel O, Lamoureux A, Gerard E, Ouhabrache N, Beylot-Barry M

doi: 10.1016/j.annder.2025.103342

Autoimmune Disease

Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry

Arthritis Res Ther

Cobo-Ibáñez T, Castellví I, Pros A, Domínguez-Álvaro M, Nuño-Nuño L, Martínez-Barrio J, Jovaní V, Romero-Bueno F, Ruiz-Lucea E, Tomero E, Trallero-Araguás E, Narváez J, Camins-Fàbregas J, Ruiz-Román A, Loarce-Martos J, Holgado-Pérez S, Flores-Rodríguez VM, Sivera F, Merino-Argumanez C, Juan-Mas A, Altabás-González I, Martín-López M, Belzunegui-Otano JM, Carrasco-Cubero C, Freire-González M, Rúa-Figueroa I, Lozano-Rivas N, Suarez-Cuba JD, Martínez O, Ortega-Castro R, Alcocer P, Gómez-Gómez A, Sánchez-Pernaute O, Tandaipan JL, Carrión-Barberà I, Plasencia-Rodríguez C, Ibarguengoitia-Barrena O, Vidal-Montal P, Ortiz-Santamaria V, Garrido-Puñal N, Riveros A, Delgado-Frías E, López-Gómez JM, Barbadillo C, Pego-Reigosa JM, Joven-Ibáñez BE, Valero-Jaimes JA, Naveda E, Turrión-Nieves AI, Seoane-Mato D, Prado-Galbarro FJ, Puche-Larrubia MÁ

doi: 10.1186/s13075-024-03471-x

Autoimmune Disease

The incidence of anti-HMGCR immune-mediated necrotising myopathy: an Australian and UK retrospective multi-site cohort study

Rheumatology (Oxford)

Khoo T, Tan E, Limaye V, Gunawardena H, Sadler R, Lamb JA, Lyu X, Brusch A, Needham M, Austin K, Bahadori A, Buch MH, Tomaszewski M, Lilleker JB, Chinoy H

doi: 10.1093/rheumatology/keaf238

Melanoma and Skin Cancer

The impact of the time-of-day in the administration of immunotherapy and its efficacy in patients with advanced melanoma: A retrospective observational study

Ann Dermatol Venereol

Amici M, Neveu E, Poizeau F, Edeline J, Lesimple T, Oger E, Danton G, Dupuy A, Fouchard M

doi: 10.1016/j.annder.2025.103371

Further Publications Immunology

Prevalence and demographics of 331 rare diseases and associated COVID-19-related mortality among 58 million individuals: a nationwide retrospective observational study

Lancet Digit Health

Thygesen JH, Zhang H, Issa H, Wu J, Hama T, Phiho-Gomes AC, Groza T, Khalid S, Lumbers TR, Hocaoglu M, Khunti K, Priedon R, Banerjee A, Pontikos N, Tomlinson C, Torralbo A, Taylor P, Sudlow C, Denaxas S, Hemingway H, Wu H, CVD-COVID-UK/COVID-IMPACT Consortium

doi: 10.1016/S2589-7500(24)00253-X

Related content

Disease characteristics and medications use in idiopathic inflammatory myopathy: a multi-center prospective observational study of decentralized remote vs. traditional clinic enrollment

Autoantibodies and damage in patients with idiopathic inflammatory myopathies: A longitudinal multicenter study from the MYONET international network

Construct validity of PROMIS pain interference, fatigue, and physical function as patient-reported outcomes in adults with idiopathic inflammatory myopathies: An international study from the OMERACT myositis working group

Recruitment rate comparison between a virtual tele-research cohort and a traditional center-based cohort in idiopathic inflammatory myopathy

Radiation therapy on lentigo maligna: A single-centre retrospective study on 91 patients

Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry

The incidence of anti-HMGCR immune-mediated necrotising myopathy: an Australian and UK retrospective multi-site cohort study

The impact of the time-of-day in the administration of immunotherapy and its efficacy in patients with advanced melanoma: A retrospective observational study

Prevalence and demographics of 331 rare diseases and associated COVID-19-related mortality among 58 million individuals: a nationwide retrospective observational study